SUBSCRIBE
SUBSCRIBE
News   Business

KineMed, Inc. Announces Extension of Its Collaboration with Bristol-Myers Squibb Company

March 9, 2011 | 
1 min read
EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today the extension of its collaboration with Bristol-Myers Squibb (NYSE: BMY) in the area of Alzheimer’s disease and other neurodegenerative conditions.
Alliances
Bristol Myers Squibb Company
MORE ON THIS TOPIC
Illustration showing hands holding arrow that goes up and down a few times and ends up in upward direction
Mergers & acquisitions
Rumors of Eli Lilly Buyout Send Nektar’s Shares Spiking
October 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Following Cancelled FDA Meeting, Kezar To Cut Employees, Eyes Strategic Alternatives
October 17, 2025
 · 
73 min read
 · 
BioSpace Editorial Staff
background, no people
Drug pricing
Novo, Lilly Shares Drop as Trump Promises $150 Ozempic
October 17, 2025
 · 
3 min read
 · 
Annalee Armstrong
Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac